Actinium Pharmaceuticals, Inc. (ATNM)
1.455
+0.04
(+2.46%)
USD |
NYAM |
Dec 11, 16:00
1.455
0.00 (0.00%)
After-Hours: 18:48
Actinium Pharmaceuticals Research and Development Expense (Quarterly): 4.042M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | 141.00M |
| Apyx Medical Corp. | 0.801M |
| AbbVie, Inc. | 2.319B |
| Karyopharm Therapeutics, Inc. | 30.42M |
| NovaBay Pharmaceuticals, Inc. | -- |